Study of vinpocetine for diabetic kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether vinpocetine, a medicine that helps blood flow, can improve kidney function in people with type 2 diabetes and moderate to advanced kidney disease (stages 3 and 4). It may offer a new way to protect your kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes.
- Your kidneys are at stage 3 or stage 4 chronic kidney disease (eGFR between 15 and 59).
- You have a small amount of protein in your urine (microalbuminuria).
- You have been on stable diabetes and kidney treatment for at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether finerenone, a medication that protects the kidneys and heart, can help African American veterans with type 2 diabetes and early kidney damage. If you qualify, you may receive the study drug and close monitoring of your kidney function and blood sugar.
This Phase 2 study tests whether adding NAD can improve kidney health in people with diabetes-related kidney disease. It is designed for people with certain urine lab results showing kidney stress, while keeping blood sugar and safety limits within range.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
This study tests a new drug called LC-Z300-01 to see if it can reduce protein in the urine of people with type 2 diabetes and diabetic kidney disease. If you have diabetic kidney disease and are already on standard kidney-protective medications, this trial may offer a potential new treatment option.
This trial tests whether oxygen therapy can help people with diabetic kidney disease. It aims to see if extra oxygen can improve kidney function and reduce protein in urine.
This study tests an investigational drug that blocks a protein called ANGPTL3, which may help protect the kidneys in people with type 2 diabetes and diabetic kidney disease. It aims to see if the drug can reduce kidney damage and improve overall health.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.